Abstract
A retrospective analysis of 108 cases of primary germ cell tumours of testis seen over a 6 year period at Institute Rotary Cancer Hospital of All India Institute of Medical Sciences, New Delhi is presented. There were 45 (42%) cases of seminoma and 63 (48%) of non-seminomatous germ cell tumours (NSGCT). The median age at presentation was 35 and 30 years respectively. Almost half (56) patients presented in advanced stage (stages IIc-IV). Tumours in undescended testis formed an important subgroup (14%). The standard approach of treatment was radiotherapy in stages I & II seminomas and chemotherapy in bulky seminomas and metastatic NSGCT. Chemotherapy protocols used were VAB-6 and PVB. Although a policy of surveillance has been practised for stage I NSGCT, it is debatable whether it is universally suitable for our patients. The results of treatment in low volume disease are comparable to that in the west but the management of bulky disease requires a more aggressive approach. Unfortunately only 74 out of 108 (68.5%) patients were able to complete the treatment prescribed. Most of the defaulters were from the chemotherapy group because of inability to afford the drugs. The probability of survival of those who completed treatment was 0.77 at 4 years. Since testicular tumours are largely curable, a more vigorous policy of detection, follow up and treatment needs to be pursued. Better screening of children with undescended testis will reduce cancer in this group. Failure to provide chemotherapy to all patients is particularly unfortunate for a curable disease like testis cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
- Graham J., Harding M., Mill L., Kerr D. J., Rankin E., Calman K. C., Kaye S. B. Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985. Br J Cancer. 1988 Feb;57(2):182–185. doi: 10.1038/bjc.1988.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grover R. K., Kaushal V., Gupta B. D. Testicular germ cell tumors. A review of 10 years' experience. Cancer. 1985 Sep 15;56(6):1251–1256. doi: 10.1002/1097-0142(19850915)56:6<1251::aid-cncr2820560605>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
- Vugrin D., Herr H. W., Whitmore W. F., Jr, Sogani P. C., Golbey R. B. VAB-6 combination chemotherapy in disseminated cancer of the testis. Ann Intern Med. 1981 Jul;95(1):59–61. doi: 10.7326/0003-4819-95-1-59. [DOI] [PubMed] [Google Scholar]